© All Rights reserved to Barnea & Co. Law Offices. 2015

Together is global

Capital Markets / Foreign Stock Exchanges

Barnea and Co. provides expert legal advice in the various issues encountered by Israeli companies traded on foreign stock exchanges (particularly in the US and the UK) and foreign investors with holdings in Israeli public companies. The firm recently handled a precedent-setting case whereby a foreign company that was traded on the Tel-Aviv Stock Exchange undertook the process of delisting from two stock exchanges in a transaction valued at NIS 350 million.

 

 

The firm’s services include coordinating the ongoing reports to the various stock exchanges, representing clients before securities authorities and other agencies, double listings, compliance with ongoing reporting requirements in two markets and more.

 

The team working in this practice area is highly familiar with the existing regulatory requirements in the capital markets in the various countries and has extensive experience integrating these requirements and the company’s requirements under Israeli law. Furthermore, Barnea & Co. has strong working relationships with law firms and investment banks operating outside of Israel, which allows the firm to provide comprehensive legal counsel.

 

Michael Barnea, who heads the Capital Markets and Securities department, has unique expertise in advising Israeli companies that are traded in London on both the main market and AIM.

 

Back to Capital Markets & Securities

News and updates - Capital Markets / Foreign Stock Exchanges:


May 24, 2017

Class Action Against Israeli Company Offering Securities Abroad – Not in Israel

It is not uncommon for Israeli incorporated companies to seek investments abroad. In many cases, such investments are done through public offerings on international stock exchanges. Securities issued by Israeli companies are traded on the NASDAQ, the London Stock Exchange and a variety of other exchanges, including Australia. These situations, which make perfect sense from a business perspective, give rise to interesting and sometimes quite complex legal issues.

April 4, 2017

The Hong Kong Stock Exchange has formally approved Israel as an ‘Acceptable Jurisdiction’.

Dr. Zvi Gabbay, Head of the Capital Markets Department at Barnea & Co. was interviewed by The Marker following the approval of the Hong Kong Stock Exchange (‘HKSE’) Israel as an ‘Acceptable Jurisdiction’. Zvi commented that the HKSE’s approval is currently limited to foreign listed Israeli public companies and Israeli private companies seeking a listing on the HKSE and it could also translate into cost savings for such companies.

March 27, 2017

Medigus Ltd. Completed a Nasdaq IPO

Barnea & Co. represented a group of US underwriters, led by H.C. Wainwright & Co., LLC, in the process of submission of Medigus Ltd. of a prospectus for the Nasdaq listing. Medigus raised USD 7.5 million and will be traded on Nasdaq in parallel with its listing on the Tel Aviv Stock Exchange. Medigus Ltd is an Israel-based company active in the medical sector. It specializes in developing endoscopic procedures and devices.

Capital Markets / Foreign Stock Exchanges

Barnea and Co. provides expert legal advice in the various issues encountered by Israeli companies traded on foreign stock exchanges (particularly in the US and the UK) and foreign investors with holdings in Israeli public companies. The firm recently handled a precedent-setting case whereby a foreign company that was traded on the Tel-Aviv Stock Exchange undertook the process of delisting from two stock exchanges in a transaction valued at NIS 350 million.

 

 

The firm’s services include coordinating the ongoing reports to the various stock exchanges, representing clients before securities authorities and other agencies, double listings, compliance with ongoing reporting requirements in two markets and more.

 

The team working in this practice area is highly familiar with the existing regulatory requirements in the capital markets in the various countries and has extensive experience integrating these requirements and the company’s requirements under Israeli law. Furthermore, Barnea & Co. has strong working relationships with law firms and investment banks operating outside of Israel, which allows the firm to provide comprehensive legal counsel.

 

Michael Barnea, who heads the Capital Markets and Securities department, has unique expertise in advising Israeli companies that are traded in London on both the main market and AIM.

 

Back to Capital Markets & Securities

News and updates - Capital Markets:


May 24, 2017

Class Action Against Israeli Company Offering Securities Abroad – Not in Israel

It is not uncommon for Israeli incorporated companies to seek investments abroad. In many cases, such investments are done through public offerings on international stock exchanges. Securities issued by Israeli companies are traded on the NASDAQ, the London Stock Exchange and a variety of other exchanges, including Australia. These situations, which make perfect sense from a business perspective, give rise to interesting and sometimes quite complex legal issues.

April 4, 2017

The Hong Kong Stock Exchange has formally approved Israel as an ‘Acceptable Jurisdiction’.

Dr. Zvi Gabbay, Head of the Capital Markets Department at Barnea & Co. was interviewed by The Marker following the approval of the Hong Kong Stock Exchange (‘HKSE’) Israel as an ‘Acceptable Jurisdiction’. Zvi commented that the HKSE’s approval is currently limited to foreign listed Israeli public companies and Israeli private companies seeking a listing on the HKSE and it could also translate into cost savings for such companies.

March 27, 2017

Medigus Ltd. Completed a Nasdaq IPO

Barnea & Co. represented a group of US underwriters, led by H.C. Wainwright & Co., LLC, in the process of submission of Medigus Ltd. of a prospectus for the Nasdaq listing. Medigus raised USD 7.5 million and will be traded on Nasdaq in parallel with its listing on the Tel Aviv Stock Exchange. Medigus Ltd is an Israel-based company active in the medical sector. It specializes in developing endoscopic procedures and devices.

Enter your email for newsletter sign up: